Recordati S.p.A. Stock (IT0003828271): Ownership Structure In Focus After Latest Filings
13.06.2026 - 21:56:29 | ad-hoc-news.deResponsible: ad hoc news Stocks & Analysis Desk. Reviewed prior to publication on June 13, 2026 at 9:55 PM ET. Details in the imprint.
Recordati S.p.A., the Italian specialty-pharma group listed in Milan, remains a closely held company with a clearly defined controlling shareholder structure that continues to shape how the stock trades on the Borsa Italiana under the ticker REC.
Shareholder structure and control remain defining features
Publicly available ownership information for Recordati shows that a majority stake is held through the FIMEI holding vehicle, historically associated with the Recordati family and more recently with long-term financial investors, leaving a free float that is meaningful but not dominant in voting terms.
Alongside the core holding, a range of institutional investors, including European asset managers and global funds, appear among the largest minority shareholders based on recent public disclosures and registry data typically compiled by market-data providers.
The company’s overall share count, market capitalization and free-float calculation are monitored by the Borsa Italiana for index inclusion purposes, with Recordati commonly referenced as part of the Italian blue-chip universe, even though its presence in specific Italian indices is subject to periodic reviews by the exchange and index administrators.
Because the controlling position is stable, changes in institutional positions in free-float shares can still influence liquidity and day-to-day price dynamics, especially around earnings releases or sector news affecting European pharmaceuticals.
Available public information indicates that Recordati has not reported disruptive changes in its ownership base in recent months, suggesting continuity in the shareholder profile, while regular regulatory filings in Italy provide oversight of significant position changes when disclosure thresholds are crossed.
For investors watching the stock, the stable control structure means corporate strategy, dividend policy and capital-allocation decisions are likely to reflect a long-term orientation, with minority shareholders participating mainly through dividends and share-price performance rather than through direct influence on governance.
Against this backdrop, Recordati’s ownership profile remains an important factor in assessing how the share price might react to company-specific news, changes in the broader pharmaceuticals sector or shifts in investor appetite for defensive healthcare names on European markets.
Recordati at a glance for equity investors
- Name: Recordati S.p.A.
- Industry: Specialty pharmaceuticals and healthcare
- Headquarters: Milan, Italy
- Core markets: Europe, with a focus on Italy and other EU countries, and selected international markets
- Revenue drivers: Prescription medicines in cardiovascular, urology and rare-disease segments, as well as selected over-the-counter brands
- Listing: Borsa Italiana, Milan - ticker REC; no primary US listing, potential access for US investors via international brokerage platforms
- Trading currency: Euro (EUR)
More updates on Recordati
Follow additional regulatory disclosures, financial updates and news flows around Recordati via the dedicated topic overview on ad hoc news.
More Recordati S.p.A. news Investor RelationsThis article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.
